Semaglo OB 1 mg is a once-weekly injectable medication containing Semaglutide, a GLP-1 receptor agonist. It is used to improve blood sugar control in adults with Type 2 Diabetes Mellitus and to support weight management in individuals with obesity or overweight conditions linked to comorbidities like high blood pressure, dyslipidemia, or diabetes.